Senior Statistical Programmer - Late-Stage Oncology (Remote)

Merck & Co.; Rahway (NJ); Remote; USD 117,000 - 184,000; Full time

Benefits offered by this job

Medical insurance

Dental insurance

Vision insurance

401(k)

Paid holidays

Vacation days

Job summary

Merck & Co. is seeking an experienced Statistical Programmer in BARDS to support late-stage drug/vaccine development programs.

You will lead programming activities, develop analysis datasets, and generate tables, listings, and figures for regulatory submissions. The role requires strong SAS skills, CDISC/ADaM familiarity, and the ability to collaborate across clinical development, outcomes research, and safety groups.

Qualifications

• BA/BS or MS with SAS programming in a clinical trial setting.
• Experience designing and maintaining analysis datasets, tables, listings and figures.
• Ability to lead projects and coordinate global programming teams.

Responsibilities

• Lead statistical programming deliverables across trials and regulatory submissions.
• Design and maintain statistical datasets for multiple stakeholders.
• Collaborate with statistics and other project teams to ensure timely quality deliverables.
• Serve as programming point of contact through the product lifecycle.

Skills

Interpersonal skills

Leadership

Project leadership

Stakeholder management

Numerical analysis

Clinical development understanding

Statistical programming

Education

BA/BS in Computer Science, Statistics, Applied Mathematics, Life Sciences, Engineering or related field

MS in Computer Science, Statistics, Applied Mathematics, Life Sciences, Engineering or related field

Tools

SAS

SAS/MACRO

SAS/GRAPH

Job description

Merck & Co. is seeking an experienced Statistical Programmer in BARDS to support late-stage drug/vaccine development programs.

You will lead programming activities, develop analysis datasets, and generate tables, listings, and figures for regulatory submissions. The role requires strong SAS skills, CDISC/ADaM familiarity, and the ability to collaborate across clinical development, outcomes research, and safety groups.